{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:53:59Z","timestamp":1761598439986,"version":"build-2065373602"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.berh.2022.101759","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T19:47:02Z","timestamp":1655581622000},"page":"101759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How to implement guidelines and models of care"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-9146","authenticated-orcid":false,"given":"Piet","family":"Geusens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":false,"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-3423","authenticated-orcid":false,"given":"M.","family":"Carola Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3166-6951","authenticated-orcid":false,"given":"Hanna","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-3953","authenticated-orcid":false,"given":"Willem F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-2232","authenticated-orcid":false,"given":"Joop","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00198-020-05756-8","article-title":"Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review","volume":"32","author":"Burden","year":"2021","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-016-3894-y","article-title":"Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures","volume":"28","author":"Harvey","year":"2017","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jocd.2017.06.008","article-title":"Worldwide fracture prediction","volume":"20","author":"El-Hajj Fuleihan","year":"2017","journal-title":"J Clin Densitom : the official journal of the International Society for Clinical Densitometry"},{"issue":"10","key":"10.1016\/j.berh.2022.101759_bib4","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-019-05226-w","article-title":"Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis","volume":"31","author":"Merlijn","year":"2020","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00198-020-05377-1","volume":"31","author":"Javaid","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2022.101759_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211024029","article-title":"Opportunistic diagnosis of osteoporosis, fragile bone strength and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to implementation","volume":"13","author":"Aggarwal","year":"2021","journal-title":"Therapeutic advances in musculoskeletal disease"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jbmr.3429","article-title":"High imminent vertebral fracture risk in subjects with COPD with a prevalent or incident vertebral fracture","volume":"33","author":"van Dort","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jbmr.3672","article-title":"Thoracic kyphosis on chest CT scans is associated with incident vertebral fractures in smokers","volume":"34","author":"van Dort","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-020-05804-3","article-title":"Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services","volume":"32","author":"Lems","year":"2021","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","article-title":"Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures","volume":"31","author":"Kanis","year":"2020","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.berh.2022.101759_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jbmr.3815","article-title":"The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial","volume":"34","author":"Merlijn","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"10122","key":"10.1016\/j.berh.2022.101759_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00198-019-05270-6","article-title":"Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study","volume":"31","author":"Condurache","year":"2020","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40520-018-1109-4","article-title":"Scientific Advisory Board of the European Society for C, Economic Aspects of O, et al. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"31","author":"Kanis","year":"2019","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Archives of osteoporosis"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00198-021-05962-y","article-title":"Short time horizons for fracture prediction tools: time for a rethink","volume":"32","author":"McCloskey","year":"2021","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00198-017-3976-5","article-title":"Imminent fracture risk","volume":"28","author":"Roux","year":"2017","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00198-019-04852-8","article-title":"Risk of imminent fracture following a previous fracture in a Swedish database study","volume":"30","author":"Banefelt","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","article-title":"Risk of subsequent fracture after prior fracture among older women","volume":"30","author":"Balasubramanian","year":"2019","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10507","article-title":"Refracture and mortality following hospitalization for severe osteoporotic fractures: the Fractos Study","volume":"5","author":"Roux","year":"2021","journal-title":"JBMR Plus"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jbmr.3953","article-title":"History of previous fracture and imminent fracture risk in Swedish women aged 55 to 90 Years presenting with a fragility fracture","volume":"35","author":"Toth","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00198-020-05772-8","article-title":"Risk factors for imminent fractures: a substudy of the FRISBEE cohort","volume":"32","author":"Iconaru","year":"2021","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","article-title":"Imminent risk of fracture after fracture","volume":"28","author":"Johansson","year":"2017","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.berh.2022.101759_bib26","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention","volume":"27","author":"Eisman","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/annrheumdis-2016-210289","article-title":"EULAR\/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures","volume":"76","author":"Lems","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.berh.2019.101430","article-title":"Fragility fractures - global call to action","volume":"33","author":"Dreinhofer","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-020-05308-0","article-title":"Interventions to improve osteoporosis care: a systematic review and meta-analysis","volume":"31","author":"Martin","year":"2020","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.berh.2022.101759_bib30","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00198-017-4147-4","article-title":"Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture","volume":"28","author":"van der Velde","year":"2017","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib31","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00198-019-05016-4","article-title":"Challenges and opportunities to improve fracture liaison service attendance: fracture registration and patient characteristics and motivations","volume":"30","author":"van den Berg","year":"2019","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.berh.2022.101759_bib32","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00198-020-05442-9","article-title":"Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires","volume":"31","author":"van den Berg","year":"2020","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00223-017-0284-1","article-title":"The phenotype of patients with a recent fracture: a literature survey of the fracture liaison service","volume":"101","author":"Vranken","year":"2017","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00198-017-4290-y","article-title":"Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service","volume":"29","author":"Vranken","year":"2018","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.berh.2022.101759_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12018-018-9253-0","article-title":"Systemic bone loss after fracture","volume":"16","author":"Osipov","year":"2018","journal-title":"Clin Rev Bone Miner Metabol"},{"issue":"9","key":"10.1016\/j.berh.2022.101759_bib36","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00198-019-05081-9","article-title":"The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service","volume":"30","author":"Vranken","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2022.101759_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2474-14-121","article-title":"The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality","volume":"14","author":"Huntjens","year":"2013","journal-title":"BMC Muscoskel Disord"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12891-021-04051-9","article-title":"Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada","volume":"22","author":"Adachi","year":"2021","journal-title":"BMC Muscoskel Disord"},{"issue":"11","key":"10.1016\/j.berh.2022.101759_bib39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","article-title":"Determinants of imminent fracture risk in postmenopausal women with osteoporosis","volume":"31","author":"Barron","year":"2020","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.berh.2022.101759_bib40","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00198-017-4103-3","article-title":"Predictors of near-term fracture in osteoporotic women aged >\/=65 years, based on data from the study of osteoporotic fractures","volume":"28","author":"Weycker","year":"2017","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-021-06165-1","article-title":"Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM)","volume":"33","author":"Moller","year":"2022","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamainternmed.2021.2617","article-title":"Risk of subsequent fractures in postmenopausal women after nontraumatic vs traumatic fractures","volume":"181","author":"Crandall","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.berh.2022.101759_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00198-019-04919-6","article-title":"Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression","volume":"30","author":"Beaudoin","year":"2019","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11914-021-00659-x","article-title":"Approaches to fracture risk assessment and prevention","volume":"19","author":"Baim","year":"2021","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-022-00717-y","article-title":"Evaluating patients for secondary causes of osteoporosis","volume":"20","author":"Lewiecki","year":"2022","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2013.05.002","article-title":"Comparison of different screening tools (FRAX(R), OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study","volume":"56","author":"Rubin","year":"2013","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"Scope 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Archives of osteoporosis"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11657-021-00969-8","article-title":"Osteoporosis in Europe: a compendium of country-specific reports","volume":"17","author":"Willers","year":"2022","journal-title":"Archives of osteoporosis"},{"issue":"9527","key":"10.1016\/j.berh.2022.101759_bib49","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"Sambrook","year":"2006","journal-title":"Osteoporosis. Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.berh.2022.101759_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF01623272","article-title":"Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women","volume":"3","author":"Ross","year":"1993","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-006-0306-8","article-title":"Enhanced prediction of fracture risk combining vertebral fracture status and BMD","volume":"18","author":"Siris","year":"2007","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib52","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jbmr.4134","article-title":"Defining very high fracture risk: is FRAX fit for purpose?","volume":"35","author":"Compston","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.berh.2022.101759_bib53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40520-022-02100-4","article-title":"Management of patients at very high risk of osteoporotic fractures through sequential treatments","volume":"34","author":"Curtis","year":"2022","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11657-020-00827-z","article-title":"FRAX: re-adjust or re-think","volume":"15","author":"El Miedany","year":"2020","journal-title":"Archives of osteoporosis"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11914-021-00663-1","article-title":"Anabolic agents for postmenopausal osteoporosis: how do you choose?","volume":"19","author":"Cosman","year":"2021","journal-title":"Curr Osteoporos Rep"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3423","article-title":"Osteoporosis and hip fracture risk from routine computed tomography scans: the fracture, osteoporosis, and CT utilization study (FOCUS)","volume":"33","author":"Adams","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"10102","key":"10.1016\/j.berh.2022.101759_bib57","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib58","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.3113","article-title":"Spinal loading patterns from biomechanical modeling explain the high incidence of vertebral fractures in the thoracolumbar region","volume":"32","author":"Bruno","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jbmr.3381","article-title":"The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study","volume":"33","author":"Turner","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib60","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1210\/jc.2018-02614","article-title":"Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implications for fracture prevention","volume":"104","author":"Mai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","article-title":"A broader strategy for osteoporosis interventions","volume":"16","author":"Reid","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"10329","key":"10.1016\/j.berh.2022.101759_bib62","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib63","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.berh.2022.101759_bib64","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fphar.2019.00882","article-title":"Does routine anti-osteoporosis medication lower the risk of fractures in male subjects? An updated systematic review with meta-analysis of clinical trials","volume":"10","author":"Zeng","year":"2019","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib65","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society\u2217 clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.berh.2022.101759_bib66","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"issue":"25","key":"10.1016\/j.berh.2022.101759_bib68","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib69","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib70","first-page":"195","article-title":"Romosozumab versus alendronate and fracture risk in women with osteoporosis","volume":"378","author":"Saag","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101759_bib71","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","article-title":"The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis","volume":"32","author":"Li","year":"2021","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"issue":"10117","key":"10.1016\/j.berh.2022.101759_bib73","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib74","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jbmr.3384","article-title":"Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial","volume":"33","author":"Geusens","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.berh.2022.101759_bib75","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/BOR.0000000000000509","article-title":"Long-term treatment strategies for postmenopausal osteoporosis","volume":"30","author":"Cosman","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib76","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"Schwartz","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","article-title":"Denosumab in the treatment of osteoporosis: 10 Years later: a narrative review","volume":"39","author":"Kendler","year":"2022","journal-title":"Adv Ther"},{"issue":"12","key":"10.1016\/j.berh.2022.101759_bib78","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00198-019-05146-9","article-title":"Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab","volume":"30","author":"Kendler","year":"2019","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.berh.2022.101759_bib79","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.080805","article-title":"Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans","volume":"23","author":"Keaveny","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"9999","key":"10.1016\/j.berh.2022.101759_bib80","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.berh.2022.101759_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00223-019-00563-8","article-title":"Long-term effects of teriparatide followed by antiresorptive therapy on clinical outcomes in patients with severe spinal osteoporosis","volume":"105","author":"Oswald","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"15","key":"10.1016\/j.berh.2022.101759_bib82","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib83","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jbmr.3427","article-title":"FRAME study: the foundation effect of building bone with 1 Year of romosozumab leads to continued lower fracture risk after transition to denosumab","volume":"33","author":"Cosman","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib84","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.berh.2022.101759_bib85","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib86","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jbmr.3722","article-title":"Relationship between bone mineral density T-score and nonvertebral fracture risk over 10 Years of denosumab treatment","volume":"34","author":"Ferrari","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.berh.2022.101759_bib87","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamainternmed.2014.1232","article-title":"Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study","volume":"174","author":"Bauer","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.berh.2022.101759_bib88","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2014-1971","article-title":"Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?","volume":"99","author":"Cosman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.berh.2022.101759_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115574","article-title":"Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis","volume":"140","author":"Ebina","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.berh.2022.101759_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115833","article-title":"The treatment gap: the missed opportunities for osteoporosis therapy","volume":"144","author":"Fuggle","year":"2021","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.berh.2022.101759_bib91","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-020-05378-0","article-title":"Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review","volume":"31","author":"Cornelissen","year":"2020","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib92","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11914-020-00644-w","article-title":"Closing the osteoporosis care gap","volume":"19","author":"Akesson","year":"2021","journal-title":"Curr Osteoporos Rep"},{"issue":"9391","key":"10.1016\/j.berh.2022.101759_bib93","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet (London, England)"},{"issue":"15","key":"10.1016\/j.berh.2022.101759_bib94","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158365","article-title":"Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients' and practitioners' views","volume":"11","author":"Alami","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib96","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11657-019-0599-9","article-title":"Primary care physicians' views on osteoporosis management: a qualitative study","volume":"14","author":"Salminen","year":"2019","journal-title":"Archives of osteoporosis"},{"key":"10.1016\/j.berh.2022.101759_bib97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11657-012-0088-x","article-title":"General medical practitioners' knowledge and beliefs about osteoporosis and its investigation and management","volume":"7","author":"Otmar","year":"2012","journal-title":"Archives of osteoporosis"},{"issue":"1","key":"10.1016\/j.berh.2022.101759_bib98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstrom","year":"2020","journal-title":"Archives of osteoporosis"},{"issue":"6","key":"10.1016\/j.berh.2022.101759_bib99","first-page":"CD000259","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:55Z","timestamp":1761499375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1521694222000183"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101759","relation":{},"ISSN":["1521-6942"],"issn-type":[{"type":"print","value":"1521-6942"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to implement guidelines and models of care","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101759"}}